Predicting health care utilization in systemic lupus erythematosus (SLE): Country of care, disease damage and health status.

被引：0
|
作者：
Clarke, AE
Petri, M
Manzi, S
Isenberg, DA
Gordon, C
Senecal, JL
St Pierre, Y
Joseph, L
Penrod, J
Fortin, PR
Sutcliffe, N
Goulet, JR
Choquette, D
Grodzicky, T
Esdaile, JM
机构：
[1] Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada
[2] Johnson Hopkins, Baltimore, MD 21205 USA
[3] Univ Pittsburgh, Pittsburgh, PA 15213 USA
[4] UCL, London W1P 9PG, England
[5] Univ Birmingham, Birmingham B15 2TT, W Midlands, England
[6] Univ Montreal, Notre Dame Hosp, Montreal, PQ H2L 4M1, Canada
[7] Univ British Columbia, Vancouver, BC V5Z 1L7, Canada
来源：
ARTHRITIS AND RHEUMATISM | 1998年 / 41卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1144
引用
收藏
页码：S223 / S223
页数：1
相关论文
共 50 条
  • [41] Associates of health status in patients with systemic lupus erythematosus
    Sutcliffe, N
    Clarke, AE
    Levinton, C
    Frost, C
    Gordon, C
    Isenberg, DA
    JOURNAL OF RHEUMATOLOGY, 1999, 26 (11) : 2352 - 2356
  • [42] Socioeconomic status and health in women with systemic lupus erythematosus
    Lotstein, DS
    Ward, MM
    Bush, TM
    Lambert, RE
    van Vollenhoven, R
    Neuwelt, CM
    JOURNAL OF RHEUMATOLOGY, 1998, 25 (09) : 1720 - 1729
  • [43] CLINICAL CHARACTERISTICS, HEALTH CARE RESOURCE UTILIZATION, AND COSTS ASSOCIATED WITH FLARES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS IN GERMANY
    Ding, B.
    Pignot, M.
    Garal-Pantaler, E.
    Villinger, B.
    Desta, B.
    Schmidt, K.
    Golam, S.
    Stirnadel-Farrant, H.
    Schwarting, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1042 - 1043
  • [44] Disease course in systemic lupus erythematosus: Changes in health status, disease activity, and organ damage after 2 years
    Gilboe, IM
    Kvien, TK
    Husby, G
    JOURNAL OF RHEUMATOLOGY, 2001, 28 (02) : 266 - 274
  • [45] Use of Quality Measures to Identify Disparities in Health Care for Systemic Lupus Erythematosus
    Arora, Shilpa
    Yazdany, Jinoos
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2020, 46 (04) : 623 - 638
  • [46] Health Care Costs With Sustained Oral Corticosteroid Use in Systemic Lupus Erythematosus
    Huang, Shirley P.
    Dersarkissian, Maral
    Gu, Yuqian M.
    Duh, Mei Sheng
    Wang, Min-Jung
    Benson, John
    Vu, Jensen Duy
    Averell, Carlyne M.
    Bell, Christopher F.
    CLINICAL THERAPEUTICS, 2023, 45 (07) : 619 - 626
  • [47] Retrospective Analysis of Disease Severity, Health Care Resource Utilization, and Costs Among Patients Initiating Belimumab for the Treatment of Systemic Lupus Erythematosus
    Lokhandwala, Tasneem
    Coutinho, Anna D.
    Bell, Christopher F.
    CLINICAL THERAPEUTICS, 2021, 43 (08) : 1320 - 1335
  • [48] A DISEASE SPECIFIC HEALTH RELATED QUALITY OF LIFE MEASURE FOR ADULTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
    McElhone, Kathy
    Abbott, Janice
    Franklin-Stevens, Ada
    Isenberg, David
    Griffiths, Bridget
    Gordon, Caroline
    Shelmerdine, Joanna
    Teh, Lee-Sean
    QUALITY OF LIFE RESEARCH, 2004, 13 (09) : 1554 - 1554
  • [49] Association of health status with fibromyalgia (FM) tender points (TP) in systemic lupus erythematosus (SLE) patients
    Akkasilpa, S
    Minor, M
    Goldman, D
    Petri, M
    Magder, L
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 1070 - 1070
  • [50] Disease activity, cumulative damage and quality of life in systemic lupus erythematosus (SLE).
    Hanly, JG
    ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 264 - 264
12345